Prices delayed by at least 15 minutes | Print
Arecor Therapeutics PLC (AREC)
ORD GBP0.01Open
38.00p
Previous close
38.00p
Trade high
39.40p
Volume
47,228
Year high
170.00p
Year low
35.40p
Dividend yield
–
Market capitalisation
£14.35 mn
P/E ratio
–
ISIN
GB00BMWLM973
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing medicines to market through the enhancement of existing therapeutic products. By applying an proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, Germany, Italy, the Rest of Europe, the USA, and India, out of which the majority is from the UK.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 28/04/2025 | 10:46:07 | 38.5 | 21,634 | 8,329.09 |
| 28/04/2025 | 10:30:42 | 39.4 | 25,371 | 9,996.17 |
| 28/04/2025 | 11:20:59 | 36.6 | 223 | 81.62 |
| 25/04/2025 | 08:36:15 | 40 | 2 | 0.80 |
| 24/04/2025 | 04:10:30 | 38.14 | 25,000 | 9,535.00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.